Study Of An Investigational Drug For Relapsing Multiple Sclerosis
Seeking adults aged 81-60 with relapsing multiple sclerosis for a study of an investigational drug given as a weekly injection.
Seeking adults aged 81-60 with relapsing multiple sclerosis for a study of an investigational drug given as a weekly injection.
Seeking adults aged 18 to 65 with relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS) for a study of an investigational formulation of the drug Ocrelizumab.
Seeking adults aged 18-90 who have experienced an ischemic stroke (due to reduced blood flow to the brain) in the past 24 hours and have limited treatment options for a study of an investigational drug.
Seeking men and women diagnosed with Multiple sclerosis (MS) within the past 2 years for a study of whether ocrelizumab (study drug) can be used for a period of time rather than permanently and still control your early relapsing MS disease activity.
Seeking men and women with relapsing multiple sclerosis whose doctors has decided to start treatment with clabridine tablets because other pills were not working well.